![Ignacio Moraga](http://cdn-acquia.dundee.ac.uk/sites/default/files/styles/card/public/2021-10/IgnacioMoraga.jpg?itok=tU-E5mZD&h=f4f07e78)
Press release
The acidity of tumours impairs the effectiveness of anti-cancer therapies, according to a University of Dundee study that could lead to a new generation of immunotherapy treatments
Press release
The acidity of tumours impairs the effectiveness of anti-cancer therapies, according to a University of Dundee study that could lead to a new generation of immunotherapy treatments
Press release
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own work, free of charge
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee has received an award of funding to develop a new therapeutic approach for inflammatory disorders, including inflammatory bowel disease (IBD)
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
News
Professor Grahame Hardie, from the School of Life Sciences, has been awarded the prestigious Sir Philip Randle Lecture in recognition of his record of excellence in biochemistry
News
Martin Balcerowicz joined the School in January to establish his own laboratory in the Division of Plant Sciences.
News
Kirby Swatek opened an independent research laboratory in the MRC PPU at the beginning of 2022.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
Press release
The University of Dundee has welcomed the signing of the Tay Cities Deal, which will boost efforts to capitalise on our world-class strengths in biomedicine and forensic science, creating hundreds of new jobs and attracting further investment.
Press release
A University of Dundee spinout company developing treatments for eczema, rheumatoid arthritis and other inflammatory conditions has completed its first round of private investment.
News
The o2h human health EIS Fund has announced its intention to lead an investment into In4Derm.
Press release
The University of Dundee has been named the best seat of learning in Scotland for supporting spinout businesses, according to new rankings
Press release
Three spinout projects from the University of Dundee with the potential to deliver significant healthcare benefits have received more than £250,000 from Scottish Enterprise to support their development.
Press release
The University of Dundee is to partner with global biopharmaceutical company Almirall to develop new treatments for severe skin diseases with high level of unmet medical need.
Press release
Researchers at the University of Dundee are looking to transform pharmaceutical and cosmetics testing with their spinout venture that offers an alternative for many experiments currently only performed in animals.
News
The finalists for Converge 2020, Scotland’s leading academic company creation programme, have been announced with representation from the School included on the list with Dr Robyn Hickerson, Co-founder and Chief Scientific Officer of Ten Bio.
Press release
University of Dundee researchers hope to turn their spinout venture into a biotech company worth hundreds of millions of pounds by helping to treat people with eczema, rheumatoid arthritis and other inflammatory conditions.
Press release
The Universities of Dundee and Edinburgh are playing key roles in a €77.7 million pan-European consortium seeking to accelerate the development of therapies for Covid-19 and future coronaviruses.